Posts with tag: hiking
Eli Lilly's Q4 earnings beat estimates, sending shares up 2%. Revenue increased 45% to $13.5 billion, driven by GLP-1 drugs Mounjaro and Zepbound. Mounjaro alone brought in $11.5 billion, but missed Wall Street estimates. The company raised its 2025 guidance to $58-$61 billion.
Published on: February 06, 2025, 04:02 PM UTC
Honeywell (HON) Announces Separation Into Three Public Companies: Honeywell Automation, Honeywell Aerospace, and Advanced Materials
Published on: February 06, 2025, 03:02 PM UTC
Compare taxes: Sweden's pre-filled returns vs. the US's complex, 13-hour process. See why the US tax code is so complicated and how it could be simplified.
Published on: February 06, 2025, 02:03 PM UTC
Gold prices rise to record highs as central banks and investors seek safe haven amid escalating tariffs and geopolitical tensions, surpassing $2,877 per ounce.
Published on: February 06, 2025, 07:02 AM UTC
Molina Healthcare (NYSE:MOH) reports better-than-expected Q4 revenue of $10.5 billion, exceeding estimates by 1.9%. However, EPS of $4.44 falls below analysts' expectations, with a 19% miss. Guidance for 2025 includes revenue of $44 billion and EPS of $22.50, slightly beating and missing estimates, respectively.
Published on: February 05, 2025, 10:09 PM UTC
Alpha and Omega Semiconductor Ltd. reports a loss of $6.6 million in its fiscal second quarter, with revenue of $173.2 million. For the current quarter, Alpha and Omega expects revenue in the range of $148 million to $168 million.
Published on: February 05, 2025, 10:08 PM UTC
Align Technology (NASDAQ: ALGN) reports inline Q4 results; revenue meets expectations but next quarter's guidance disappoints. Revenue up 4% year-over-year, non-GAAP EPS in line at $2.44 per share. Despite Q4 and 2024 results, revenue guidance for Q1 2025 falls below estimates. Find out more in our full research report.
Published on: February 05, 2025, 10:04 PM UTC
Chicago Fed President Goolsbee warns against ignoring potential inflationary impact of tariffs, citing supply chain disruptions during COVID-19 pandemic.
Published on: February 05, 2025, 08:00 PM UTC
Shares of toymaker Mattel (MAT) soared 16.5% after the company reported Q4 results that beat expectations. Revenue also exceeded estimates, and guidance outperformed Wall Street. Is it a buy?
Published on: February 05, 2025, 07:05 PM UTC
Polestar feels the pain of tariffs on Chinese goods, but local production in the US and elsewhere immunizes the company from some of the impact.
Published on: February 05, 2025, 07:02 PM UTC